111 related articles for article (PubMed ID: 2051018)
1. Preparation of soluble murine IL-6 receptor and anti-murine IL-6 receptor antibodies.
Saito T; Yasukawa K; Suzuki H; Futatsugi K; Fukunaga T; Yokomizo C; Koishihara Y; Fukui H; Ohsugi Y; Yawata H
J Immunol; 1991 Jul; 147(1):168-73. PubMed ID: 2051018
[TBL] [Abstract][Full Text] [Related]
2. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection.
Honda M; Yamamoto S; Cheng M; Yasukawa K; Suzuki H; Saito T; Osugi Y; Tokunaga T; Kishimoto T
J Immunol; 1992 Apr; 148(7):2175-80. PubMed ID: 1545125
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells.
Yasukawa K; Saito T; Fukunaga T; Sekimori Y; Koishihara Y; Fukui H; Ohsugi Y; Matsuda T; Yawata H; Hirano T
J Biochem; 1990 Oct; 108(4):673-6. PubMed ID: 2292596
[TBL] [Abstract][Full Text] [Related]
4. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies.
Hirata Y; Taga T; Hibi M; Nakano N; Hirano T; Kishimoto T
J Immunol; 1989 Nov; 143(9):2900-6. PubMed ID: 2681418
[TBL] [Abstract][Full Text] [Related]
5. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
[TBL] [Abstract][Full Text] [Related]
6. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
Matsuda T; Hirano T; Kishimoto T
Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
[TBL] [Abstract][Full Text] [Related]
7. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
8. Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies.
Liautard J; Gaillard JP; Mani JC; Montero-Julian F; Duperray C; Lu ZY; Jourdan M; Klein B; Brailly H; Brochier J
Eur Cytokine Netw; 1994; 5(3):293-300. PubMed ID: 7524715
[TBL] [Abstract][Full Text] [Related]
9. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo.
Suzuki H; Yasukawa K; Saito T; Goitsuka R; Hasegawa A; Ohsugi Y; Taga T; Kishimoto T
Eur J Immunol; 1992 Aug; 22(8):1989-93. PubMed ID: 1639101
[TBL] [Abstract][Full Text] [Related]
10. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 and its receptor in the immune response and hematopoiesis.
Hirano T; Taga T; Matsuda T; Hibi M; Suematsu S; Tang B; Murakami M; Kishimoto T
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():155-66; discussion 166-7. PubMed ID: 2324554
[TBL] [Abstract][Full Text] [Related]
14. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
15. The characteristics of a monoclonal antibody that binds specifically to rat T lymphoblasts and inhibits IL 2 receptor functions.
Osawa H; Diamantstein T
J Immunol; 1983 Jan; 130(1):51-5. PubMed ID: 6401187
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin 6 receptor is biologically active in vivo.
Mackiewicz A; Wiznerowicz M; Roeb E; Karczewska A; Nowak J; Heinrich PC; Rose-John S
Cytokine; 1995 Feb; 7(2):142-9. PubMed ID: 7780033
[TBL] [Abstract][Full Text] [Related]
17. The murine anti-human common gamma chain monoclonal antibody CP.B8 blocks the second step in the formation of the intermediate affinity IL-2 receptor.
Baker DP; Whitty A; Zafari MR; Olson DL; Hession CA; Miatkowski K; Avedissian LS; Foley SF; McKay ML; Benjamin CD; Burkly LC
Biochemistry; 1998 Oct; 37(41):14337-49. PubMed ID: 9772159
[TBL] [Abstract][Full Text] [Related]
18. Retention of ligand binding activity by the extracellular domain of the IL-1 receptor.
Dower SK; Wignall JM; Schooley K; McMahan CJ; Jackson JL; Prickett KS; Lupton S; Cosman D; Sims JE
J Immunol; 1989 Jun; 142(12):4314-20. PubMed ID: 2524527
[TBL] [Abstract][Full Text] [Related]
19. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
20. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.
Yasukawa K; Futatsugi K; Saito T; Yawata H; Narazaki M; Suzuki H; Taga T; Kishimoto T
Immunol Lett; 1992 Feb; 31(2):123-30. PubMed ID: 1740350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
